ATBECHDEDKESFRGBGRITLILUNLSEMC......................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0587749A119940323EP92913290.01992052219931130enenen1991070787919910531US1994032319941219940323199412

A61K 31/ 70 A I

A61K 8/ 55 A I

A61K 47/ 48 A I

A61K 48/ 00 A I

A61P 9/ 12 A I

A61P 29/ 00 A I

A61P 35/ 00 A I

A61P 43/ 00 A I

A61Q 7/ 00 A I

C07H 21/ 00 A I

C12N 15/ 113 A I

enCOMPOSITIONS AND DELIVERY SYSTEMS FOR TRANSDERMAL ADMINISTRATION OF NEUTRAL OLIGOMERSfrCOMPOSITIONS ET SYSTEMES D'APPORT DESTINES A L'ADMINISTRATION PAR VOIE TRANSDERMIQUE D'OLIGOMERES NEUTRESdeZUSAMMENSETZUNGEN UND FREISETZUNGSSYSTEME FÜR DIE TRANSDERMALE VERABREICHUNG VON NEUTRALEN OLIGOMERENGENTA INCORPORATED3055 General Atomics CourtSan Diego, CA 92121USARNOLD, Lyle J., Jr.5439 Noah WaySan Diego, CA 92117USMAXWELL, Kameron16035 Avenida CalmaRancho Santa Fe, CA 92067USSexton, Jane Helen, et alJ.A. KEMP & CO. 14 South Square Gray's InnLondon WC1R 5LXGBATBECHDEDKESFRGBGRITLILUMCNLSEUS199200437019920522enWO199202135319921210199231